Lupus

Systemic lupus erythematosus, often called SLE, is a complex autoimmune disease. In an autoimmune condition, the body's immune system loses its ability to distinguish between foreign invaders and healthy cells. Instead of protecting the body, the immune system mistakenly attacks healthy tissues in many different parts of the body. Because the symptoms are so diverse and unpredictable, doctors often refer to SLE as "the great imitator." This is because the signs of the disease can easily be mistaken for many other medical conditions.

The biological mechanism of SLE involves a specific immune response. The body produces autoantibodies, which are proteins that mistakenly target the person's own tissues. A very common type of these is the anti-nuclear antibody. When these autoantibodies attach to healthy cells, they trigger inflammation. Inflammation is the body's response to injury, but in SLE, it causes damage to healthy organs. This process can lead to various complications in the skin, joints, and internal systems.

Lupus can manifest in several different ways depending on which parts of the body are attacked. There are different types of lupus erythematosus, such as discoid lupus erythematosus, which involves thick, red, scaly skin patches. Subacute cutaneous lupus erythematosus also causes red, scaly patches but with distinct edges. Acute cutaneous lupus erythematosus typically manifests as a rash. A very famous sign is the malar rash, often called a butterfly rash, which appears on the face in 30% to 60% of people with SLE.

The history of the name lupus dates back to the 13th century. The word is Latin for "wolf." Early observers gave the disease this name because the red rashes looked like the bite of a wolf. While we now understand the science of autoantibodies, the name has remained. Scientists are still working to find the exact cause of SLE. They believe it is caused by a combination of genetic factors and environmental triggers. For example, sunlight, smoking, and vitamin D deficiency are believed to increase the risk.

Statistics show that SLE affects different groups of people in different ways. The disease is much more common in women, especially those of childbearing age, who are affected nine times more often than men. It most commonly begins between the ages of 15 and 45. People of African, Caribbean, and Chinese descent face a higher risk than those of European descent. Globally, the rate of SLE varies from 20 to 70 cases per 100,000 people.

SLE can impact almost every system in the human body. More than 90% of patients experience joint or muscle pain, though lupus arthritis is usually less disabling than rheumatoid arthritis. The disease can cause serious issues in the heart, such as pericarditis, which is inflammation of the tissue surrounding the heart. It can also affect the kidneys, sometimes leading to lupus nephritis and kidney failure. In some cases, it impacts the central nervous system, causing headaches, seizures, or even mood disorders.

Managing SLE is a continuous process because the disease often moves through cycles. Patients experience "flares," which are periods when symptoms become active and severe. These are often followed by periods of "remission," where symptoms are few or absent. While there is currently no cure for SLE, there are many ways to treat the symptoms. Doctors may use NSAIDs, corticosteroids, or immunosuppressants to manage inflammation. However, long-term use of certain medicines, like corticosteroids, can lead to their own side effects.